Julie leads research and development for the Mundipharma network outside the US, guiding a portfolio of medicines through clinical trials to registration and reimbursement.
She joined Mundipharma from Purdue Pharma Canada where she was Vice President, Research and Development. Previously, Julie led the research and development of biologics and vaccines as General Manager of Human Health Therapeutics at the National Research Council of Canada (NRC), transforming it into one of NRC’s leading portfolios. Her move to the NRC followed almost 16 years at AstraZeneca in senior leadership roles building and leading cross-functional international teams. Earlier in her career, Julie spent nine years in clinical research in academia and the pharmaceutical industry.
Julie is also an adjunct Professor of Pharmacy at the Université de Montréal and sits on several scientific advisory boards. She holds a PhD from the University of Montreal, Canada, post-doctorates from Université Paris VI, France, and McGill University, Canada, and is fluent in both French and English.
Press return to search